Caredex(CDNA.US)

Last Updated 19:00:00 ET
longbridge loading

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans

Market Beat·
US
CDNA
+3.64%
Market Beat·
US
CDNA
+3.64%

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

Market Beat·
US
CDNA
+3.64%
Market Beat·
US
CDNA
+3.64%

CareDx to Participate in Upcoming Investor Conferences | CDNA Stock News

StockTitan·
US
CDNA
+3.64%
US
IDNA
+0.48%
US
BIB
+3.07%
StockTitan·
US
CDNA
+3.64%
US
IDNA
+0.48%
US
BIB
+3.07%

CareRx declares CAD 0.02 dividend

businessinsider·
US
CDNA
+3.64%
US
IHF
+1.94%
businessinsider·
US
CDNA
+3.64%
US
IHF
+1.94%

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News

StockTitan·
US
CDNA
+3.64%
US
IHF
+1.94%
US
BBH
+0.77%
StockTitan·
US
CDNA
+3.64%
US
IHF
+1.94%
US
BBH
+0.77%

CareDx shares are trading lower after the company disclosed it filed for a mixed shelf.

benzinga_article·
US
CDNA
+3.64%
benzinga_article·
US
CDNA
+3.64%
© 2026 Longbridge｜Disclaimer